Microdosing GLP-1/GIP therapies may help: Improve glycemic control, stable blood glucose levels, and blood pressure support Reduction in visceral fat and waist circumference Potential improvements in lipid profiles Reduce systemic inflammation markers associated with cardiometabolic disease Glycine amino acid that supports protein synthesis, endothelial function, and insulin sensitivity Reduce cardiovascular risk factors such as insulin resistance and central adiposity Whats Included Monthly compounded tirzepatide + glycine (Up to 3mg/week) or 2ml tirzepatide with B12 every 2 months with labs Personalized microdosing protocol Ongoing provider oversight with labs every six months This is not an FDA-approved microdosing regimen
This program marks a significant shift in Medicare policy, as traditional Part D plans have not covered drugs primarily for weight management
cannot afford their life-sustaining insulin (a study we would be remiss not to note was conducted before a global pandemic), we know that this problem is not unique to diabetes
As with other GLP-1 medicines, they are generally not suitable for people with a personal or family history of medullary thyroid carcinoma or MEN2, and caution is needed in people with certain gastrointestinal issues, pancreatitis concerns, gallbladder disease, or other relevant medical conditions
Now, whether you are seeking treatment for your dull skin, pigmented skin, or wrinkled skin, glutathione injections can help with all these skin concerns
It is sold under different brand names, including Ozempic and Wegovy
